I disagree…the untreated eyes continued their decline in function, according to the natural history study. Any temporary “improvement” is thought to be an artifact caused by the patient becoming “accustomed” to the measurement procedure.
The overall results are outstanding though IMO.
The doctors must be almost as pleased as the patients!
- Forums
- ASX - By Stock
- PYC
- Ann: Presentation of Clinical Proof of Concept in Lead Program
PYC
pyc therapeutics limited
Add to My Watchlist
0.35%
!
$1.44

Ann: Presentation of Clinical Proof of Concept in Lead Program, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.44 |
Change
-0.005(0.35%) |
Mkt cap ! $839.8M |
Open | High | Low | Value | Volume |
$1.44 | $1.47 | $1.40 | $368.5K | 254.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5061 | $1.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.44 | 148 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5061 | 1.415 |
1 | 2919 | 1.370 |
1 | 2500 | 1.340 |
1 | 692 | 1.300 |
2 | 4196 | 1.275 |
Price($) | Vol. | No. |
---|---|---|
1.440 | 148 | 1 |
1.450 | 20324 | 1 |
1.460 | 4618 | 1 |
1.470 | 10039 | 2 |
1.475 | 20000 | 1 |
Last trade - 16.10pm 10/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |